T0	Disease 60 64	CPFE
T1	Disease 137 141	CPFE
T10	Chemical 837 847	nucleoside
T11	Chemical 895 904	adenosine
T12	Chemical 968 977	adenosine
T13	Disease 1014 1025	lung injury
#6	AnnotatorNotes T13	D055370
T15	Disease 1102 1106	CPFE
T16	Biomarker 1117 1165	downward trend for ENT2 (SLC29A2) in lower lobes
T17	Disease 1169 1173	CPFE
T19	Chemical 1212 1221	adenosine
T2	Chemical 291 300	adenosine
T20	Disease 1309 1313	CPFE
T21	Biomarker 1348 1407	increased expression of ADORA2B was detected in lower lobes
T22	Disease 1411 1415	CPFE
T23	Disease 1611 1615	CPFE
T24	Disease 1693 1697	CPFE
T25	Disease 1711 1732	chronic lung diseases
#15	AnnotatorNotes T25	not found
T26	Chemical 1770 1779	adenosine
T27	Biomarker 1770 1866	adenosine synthesis is increased, together with expression of its low-affinity receptor, ADORA2B
T28	Disease 1906 1910	CPFE
T3	Chemical 317 326	adenosine
T31	Disease 2102 2106	CPFE
T33	Disease 2195 2199	CPFE
T34	Disease 2302 2306	CPFE
T4	Disease 341 345	CPFE
T5	Biomarker 347 387	upper lobes often present with emphysema
T7	Biomarker 397 449	fibrotic deposition is more prevalent in lower lobes
T8	Disease 662 666	CPFE
T9	GeneFamily 823 860	Equilibrative nucleoside transporters
#1	AnnotatorNotes T0	DOID:3770, DOID:9675
T36	GeneFamily 317 336	adenosine receptors
#2	AnnotatorNotes T36	family:211
T6	Collection 347 449	upper lobes often present with emphysema, whereas fibrotic deposition is more prevalent in lower lobes
R1	Association Arg1:T6 Arg2:T4	
T37	Gene-Protein 497 501	CD39
#3	AnnotatorNotes T37	HGNC:3363
T38	Gene-Protein 503 509	ENTPD1
#4	AnnotatorNotes T38	HGNC:3363
T39	Gene-Protein 521 525	NT5E
#5	AnnotatorNotes T39	HGNC:8021
T40	Gene-Protein 515 519	CD73
#7	AnnotatorNotes T40	HGNC:8021
T41	Gene-Protein 601 605	CD73
T42	Biomarker 552 633	increased expression of the rate limiting enzyme CD73 but not CD39 in lower lobes
T43	Gene-Protein 614 618	CD39
R2	Association Arg1:T42 Arg2:T8	
T44	Gene-Protein 739 742	ADA
#8	AnnotatorNotes T44	HGNC:186
#9	AnnotatorNotes T9	not found
T45	GeneFamily 862 865	ENT
#10	AnnotatorNotes T45	not found
T46	Biomarker 823 860	Equilibrative nucleoside transporters
R3	Association Arg1:T46 Arg2:T13	
T47	GeneFamily 1084 1087	ENT
R4	Association Arg1:T16 Arg2:T17	
T14	Gene-Protein 1136 1140	ENT2
#11	AnnotatorNotes T14	HGNC:11004
T48	Gene-Protein 1142 1149	SLC29A2
#12	AnnotatorNotes T48	HGNC:11004
T18	GeneFamily 1212 1231	adenosine receptors
T49	Gene-Protein 1272 1278	ADORA1
#13	AnnotatorNotes T49	HGNC:262
T50	Gene-Protein 1282 1289	ADORA2A
#14	AnnotatorNotes T50	HGNC:263
T51	Gene-Protein 1372 1379	ADORA2B
#16	AnnotatorNotes T51	HGNC:264
R5	Association Arg1:T21 Arg2:T22	
T52	Gene-Protein 1509 1515	ADORA1
T53	Gene-Protein 1520 1527	ADORA2A
T54	Gene-Protein 1572 1578	ADORA3
#17	AnnotatorNotes T54	HGNC:268
T55	Collection 1693 1732	CPFE, as in other chronic lung diseases
T56	Gene-Protein 1859 1866	ADORA2B
R6	Association Arg1:T27 Arg2:T55	
T29	Gene-Protein 1945 1949	CD39
T57	Gene-Protein 1955 1959	CD73
T58	Gene-Protein 1965 1968	ADA
T59	Gene-Protein 1974 1978	ENT2
T60	Gene-Protein 1984 1990	ADORA1
T61	Gene-Protein 1996 2003	ADORA2A
T62	Gene-Protein 2009 2016	ADORA2B
T63	Gene-Protein 2025 2031	ADORA3
A1	Conjunction T0
A2	Conjunction T1
A3	Conjunction T4
A4	Conjunction T8
T30	Biomarker 739 760	ADA expression levels
T32	Biomarker 881 911	extracellular adenosine levels
T35	Biomarker 958 990	increased adenosine accumulation
T64	Biomarker 1191 1231	Expression levels of adenosine receptors
T65	Biomarker 1558 1578	expression of ADORA3
T66	Biomarker 1257 1289	alterations in ADORA1 or ADORA2A
T67	Biomarker 1084 1098	ENT expression
A5	Conjunction T15
A6	Conjunction T17
A7	Conjunction T20
A8	Conjunction T22
A9	Conjunction T23
A10	Conjunction T24
A11	Conjunction T28
A12	Conjunction T33
A13	Conjunction T31
A14	Conjunction T34
